World-first clinical trial for treating spinal cord injury
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord injury is a step closer with a $6.8 million Medical Research Future Fund grant.
A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the Spinal Injury Project team toward human clinical trials.
Griffith University is seeking five people living with spinal cord injury to be part of stage two of an innovative trial which will test intensive rehabilitation for those living with chronic spinal cord paralysis.
World-leading Griffith research into the development of a cell-based therapy for treating spinal cord injuries has received a $5.7m boost from the state government.
Griffith University researchers Dr Dinesh Palipana and Dr Claudio Pizzolato were beaming as they explained their breakthrough techniques for patients...
Natural compounds derived from Australian plants have been found to stimulate cells that are useful for transplantation to repair spinal cord injuries.
The Queensland Government has invested $5 million in a Griffith University pre-clinical trial to prove that a “nerve bridge” across...
Spinal cord research offering hope for the paralysed is set to get underway on the Gold Coast at Griffith University in collaboration with Harvard University.
The first real cure for spinal injury is closer at Griffith University because of a donation by the PerryCross Spinal...